LEADER 03743nam  22006495  450 
001 9910783513803321
005 20231102062825.0
010   $a0-306-48060-3
024 7 $a10.1007/b101862
035   $a(CKB)1000000000244319
035   $a(MiAaPQ)EBC197689
035   $a(MiAaPQ)EBC3035969
035   $a(DE-He213)978-0-306-48060-7
035   $a(Au-PeEL)EBL3035969
035   $a(CaPaEBR)ebr10067378
035   $a(OCoLC)923696999
035   $a(Au-PeEL)EBL197689
035   $a(OCoLC)54435618
035   $a(EXLCZ)991000000000244319
100   $a20100301d2003      u|             0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHead and Neck Cancer$b[electronic resource] /$fedited by Bruce Brockstein, Gregory Masters
205   $a1st ed. 2003.
210  1$aNew York, NY :$cSpringer US :$cImprint: Springer,$d2003.
215   $a1 online resource (X, 376 p.)
225 1 $aCancer Treatment and Research,$x2509-8497 ;$v114
311   $a1-4020-7336-4 
320   $aIncludes bibliographical references and index.
327   $aOverview of Head and Neck Cancer -- Epidemiology, Staging, and Screening of Head and Neck Cancer -- Oral Preneoplasia and Chemoprevention of Squamous Cell Carcinoma of the Head and Neck -- Early Stage Head and Neck Cancer ? Surgery -- Radiation Therapy in the Management of Early-Stage Head and Neck Cancer -- Advanced Head and Neck Cancersurgery and Reconstruction -- Modified Fractionated Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) & Re-Irradiation in Recurrent Head and Neck Carcinomas -- Organ Preservation-Induction Chemotherapy -- Organ Preservation for Advanced Head and Neck Cancer Concomitant Chemoradiation -- Unresectable, Locoregionally Advanced Head and Neck Cancer -- Nasopharyngeal Cancer -- Treatment of Metastatic Head and Neck Cancer: Chemotherapy and Novel Agents -- New Therapies for Locoregionally Advanced and Locoregionally Recurrent Head and Neck Cancer -- Quality of Life and Late Toxicities in Head and Neck Cancer -- Oral, Dental, and Supportive Care in the Cancer Patient.
330   $aExciting advances are occurring in the understanding of the molecular pathogenesis of squamous head and neck cancers. Epidemiology, staging and screening, as well as premalignancy, chemoprevention and the molecular biology of head and neck cancer, lay the groundwork for the understanding of the clinical chapters that follow. Controversial treatments will be compared to the standard management of patient care. Therapy chapters are divided into stage or category specific (resectable advanced, unresectable advanced or metastatic) problems, allowing the reader to review the current standards and options for patient types or specific patients easily. Considerations of supportive care, late toxicities and quality of life, often overlooked are reviewed in detail. This is a comprehensive summary of the current state of the art research and treatment.
410  0$aCancer Treatment and Research,$x2509-8497 ;$v114
606   $aOncology
606   $aCancer$xTreatment
606   $aCancer
606   $aOncology
606   $aCancer Therapy
606   $aCancer Biology
615  0$aOncology.
615  0$aCancer$xTreatment.
615  0$aCancer.
615 14$aOncology.
615 24$aCancer Therapy.
615 24$aCancer Biology.
676   $a616.99/491
701   $aBrockstein$b Bruce$01532154
701   $aMasters$b Gregory$01532155
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910783513803321
996   $aHead and Neck Cancer$93778229
997   $aUNINA